Cyprus: New Approaches for Treatments of Rare Kidney Diseases
September 5, 2026
Cyprus is leading a European program to seek therapeutic solutions for rare kidney diseases, specifically Alport disorders. The ALP-RARE program is funded by the European Partnership for Rare Diseases and includes experimental trials in animal models. The goal is to develop clinical studies that will test pharmaceutical substances. Alport disorders are hereditary and can lead to serious complications, such as loss of kidney function. Diagnosing these rare diseases requires complex procedures and gathering data from various sources.